🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07113990
Recruiting Not applicable

Electroacupuncture and rTMS for Post-Stroke Motor Recovery

NCT07113990 · tracked via the Priya Life Science China tracker
Sponsor
Jing Tao
Phase
Not applicable
Started
2025-08-27
Last updated
2025-09-05

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

Active EASham EAActive rTMS

Active EA: Participants will receive electroacupuncture once daily for 2 consecutive weeks (total 10 sessions). Disposable sterile needles will be inserted at standardized acupoints to achieve de qi, then connected to an electroacupuncture device for 30 minutes per session.

Sham EA: Participants will receive sham electroacupuncture once daily for 2 consecutive weeks (total 10 sessions). Disposable blunt needles will be placed at the same acupoints without skin penetration or electrical stimulation, with the electroacupuncture device turned on but delivering no current, for 30 minutes per session.

Active rTMS: Participants will receive high-frequency rTMS to the ipsilesional M1 area once daily for 2 consecutive weeks (total 10 sessions). Stimulation will be delivered with a MagPro R30 stimulator at 10 Hz, 1600 pulses per session, 4-second trains with 41-second inter-train intervals.

Study summary

This study aims to evaluate the combined efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and Electroacupuncture (EA) in improving motor function recovery post-stroke, compared to rTMS combined with sham EA. Participants will receive either active EA or sham EA alongside standard rTMS treatment. Outcomes will be assessed using standardized clinical scales and neuroimaging techniques to explore underlying neuroplasticity mechanisms.

Eligibility

Sex
ALL
Min age
40 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with stroke confirmed by neuroimaging (CT/MRI). * First-ever stroke, unilateral hemispheric lesion, related to motor dysfunction. * Age between 40 and 75 years. * Duration from stroke onset between 2 weeks and 6 months. * Brunnstrom stage II-IV. * Right-handed. * Able to understand instructions and voluntarily provide written informed consent. Exclusion Criteria: * History of epilepsy or familial epilepsy. * Motor dysfunction due to non-vascular causes (e.g., tumor, trauma). * Severe aphasia or cognitive impairment (MoCA \< 18). * Severe systemic complications (e.g., severe organ dysfunction, deep vein thrombosis). * Presence of metallic implants or contraindications for MRI. * Severe anxiety (HAMA \> 7) or depression (HAMD \> 8). * Severe spasticity (modified Ashworth ≥ 2). * Fear or intolerance of TMS or electroacupuncture. * Pregnancy, breastfeeding, or concurrent participation in other clinical trials affecting outcomes.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Fuzhou University Affiliated Provincial Hospital Fuzhou Fujian Recruiting
Fujian Provincial People's Hospital Fuzhou Fujian Not Yet Recruiting
Wenzhou Hospital of Traditional Chinese Medicine Wenzhou Zhejiang Not Yet Recruiting

More Jing Tao trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07113990 on ClinicalTrials.gov ↗ ← All trials in China